A Study of Disitamab Vedotin + Bicalutamide in HER2/AR-Positive Scrotal Paget's Disease

Abroad (travel likely)RecruitingPHASE2

Conditions

Extramammary Paget Disease · Scrotum Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Hengchuan Su, Chief physician) · suhengchuan@163.com · +8621-64175590